The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance

Table 1

New NRTIs that are approved or are undergoing clinical development.

Drug candidate	Chemical structure	Phase of development
GS-7340		II
CMX157		II
Amdoxovir		II
Festinavir		II
ELV		IIb
ATC		IIb
EFdA-TP		Preclinical development
GS-9131		I